RecruitingNot ApplicableNCT06141330

Vitamin D Supplementation in Acne

Vitamin D Supplementation in Combination With Azithromycin and Topical Retinoid for Acne: A Randomized Controlled Trial


Sponsor

HITEC-Institute of Medical Sciences

Enrollment

58 participants

Start Date

Feb 24, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to compare in acne vulgaris patients. The main question it aims to answer is: • To assess the therapeutic benefit of vitamin D supplement in acne vulgaris treatment, following a 2-month treatment regimen that includes vitamin D supplementation compared to conventional (systemic azithromycin and topical retinoid) treatment alone. Participants will receive vitamin D supplements in addition to capsule Azithromycin and topical retinoid. Researchers will compare groups to determine efficacy of Vitamin D supplements in the treatment of Acne vulgaris.


Eligibility

Min Age: 13 YearsMax Age: 40 Years

Inclusion Criteria1

  • Individuals aged between 13 and 40 years with diagnoses of Acne vulgaris are included.

Exclusion Criteria4

  • Individuals currently undergoing treatment for polycystic ovary syndrome (PCOs)
  • Those with obesity
  • Individuals employing vitamin supplementation
  • Those under the influence of topical or systemic steroids and acne treatment in the last 2 months.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTD Max Drops

Vitamin D

DRUGAzithromycin 250 milligram Oral Capsule

Anti Biotic

DRUGAdapalene

Retinoid


Locations(1)

Hitec-Ims

Islamabad, Punjab Province, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06141330


Related Trials